Literature DB >> 3104953

Behavioral sensitization to methamphetamine in the rat: an ontogenic study.

Y Fujiwara, Y Kazahaya, M Nakashima, M Sato, S Otsuki.   

Abstract

The behavioral effect of repeated methamphetamine (MAP) treatment was observed in young rat to establish the ontogenetic period crucial to methamphetamine sensitization. Animals were treated with MAP (2 mg/kg, SC) once daily for 5 days (Group 1: postnatal days 2-6, G-2: 7-11, G-3: 12-16, G-4: 17-21, G-5: 22-26, G-6: 27-31). Control animals were similarly treated with an equal volume of saline. On the 35th postnatal day, all rats were challenged with MAP (2 mg/kg, IP). Behavioral sensitization to MAP was not found in G-1, G-2, G-3 or G-4, although responsiveness to MAP was observed in rats after the 2nd postnatal day. The animals in G-5 and G-6 showed hypersensitivity to MAP in locomotor activity and stereotyped behavior. These findings indicate that the period crucial to behavioral sensitization to MAP corresponds to the period of presynaptic dopamine autoreceptor formation in the rat brain.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3104953     DOI: 10.1007/bf00518183

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  10 in total

1.  Amphetamine-induced dopaminergic hypersensitivity in guinea pigs. Implications in psychosis and human movement disorders.

Authors:  H L Klawans; D I Margolin
Journal:  Arch Gen Psychiatry       Date:  1975-06

2.  Age-related changes in the central catecholaminergic function and its interaction with methamphetamine during postnatal life in the rat.

Authors:  Y Nomura; I Yotsumoto; K Oki
Journal:  J Pharm Pharmacol       Date:  1981-04       Impact factor: 3.765

3.  Cocaine-induced behavior in the developing rat.

Authors:  L P Spear; J Brick
Journal:  Behav Neural Biol       Date:  1979-08

Review 4.  Amphetamine models of paranoid schizophrenia: an overview and elaboration of animal experimentation.

Authors:  L Kokkinidis; H Anisman
Journal:  Psychol Bull       Date:  1980-11       Impact factor: 17.737

5.  [Behavioral and neurochemical changes in pups prenatally treated with methamphetamine].

Authors:  Y Fujiwara
Journal:  Yakubutsu Seishin Kodo       Date:  1985-09

6.  Presynaptic subsensitivity as a possible basis for sensitization by long-term dopamine mimetics.

Authors:  P Muller; P Seeman
Journal:  Eur J Pharmacol       Date:  1979-04-15       Impact factor: 4.432

7.  Acute exacerbation of paranoid psychotic state after long-term abstinence in patients with previous methamphetamine psychosis.

Authors:  M Sato; C C Chen; K Akiyama; S Otsuki
Journal:  Biol Psychiatry       Date:  1983-04       Impact factor: 13.382

8.  Development of dopamine autoreceptors in the postnatal rat brain.

Authors:  T Hedner; P Lundborg
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

9.  Pre- and postnatal ontogeny and characterization of dopaminergic D2, serotonergic S2, and spirodecanone binding sites in rat forebrain.

Authors:  A Bruinink; W Lichtensteiger; M Schlumpf
Journal:  J Neurochem       Date:  1983-05       Impact factor: 5.372

10.  Ontogeny of dopamine, serotonin and spirodecanone receptors in rat forebrain--an autoradiographic study.

Authors:  L C Murrin; D L Gibbens; J R Ferrer
Journal:  Brain Res       Date:  1985-11       Impact factor: 3.252

  10 in total
  17 in total

1.  Acute and chronic methylphenidate dose-response assessment on three adolescent male rat strains.

Authors:  Pamela B Yang; Alan C Swann; Nachum Dafny
Journal:  Brain Res Bull       Date:  2006-10-19       Impact factor: 4.077

2.  Persistence of one-trial cocaine-induced behavioral sensitization in young rats: regional differences in Fos immunoreactivity.

Authors:  Sanders A McDougall; Sergios Charntikov; Anthony M Cortez; Dionisio A Amodeo; Cynthia E Martinez; Cynthia A Crawford
Journal:  Psychopharmacology (Berl)       Date:  2008-11-20       Impact factor: 4.530

3.  Ontogeny of the enhanced behavioral response to amphetamine in amphetamine-pretreated rats.

Authors:  M G Kolta; F M Scalzo; S F Ali; R R Holson
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

Review 4.  Stimulant-induced psychosis and schizophrenia: the role of sensitization.

Authors:  Hiroshi Ujike
Journal:  Curr Psychiatry Rep       Date:  2002-06       Impact factor: 5.285

5.  Pre-exposure to amphetamine but not nicotine sensitizes rats to the motor activating effect of cocaine.

Authors:  S Schenk; S Snow; B A Horger
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

6.  One-trial behavioral sensitization in preweanling rats: differential effects of cocaine, methamphetamine, methylphenidate, and D-amphetamine.

Authors:  Sanders A McDougall; Olga O Kozanian; Venuz Y Greenfield; Leslie R Horn; Arnold Gutierrez; Alena Mohd-Yusof; Kevin A Castellanos
Journal:  Psychopharmacology (Berl)       Date:  2011-05-03       Impact factor: 4.530

7.  Ontogeny of behavioral sensitization in the rat: effects of direct and indirect dopamine agonists.

Authors:  S A McDougall; M A Duke; C A Bolanos; C A Crawford
Journal:  Psychopharmacology (Berl)       Date:  1994-12       Impact factor: 4.530

8.  Long-term behavioral effects in a rat model of prolonged postnatal morphine exposure.

Authors:  Michael M Craig; Dusica Bajic
Journal:  Behav Neurosci       Date:  2015-07-27       Impact factor: 1.912

9.  Importance of environmental context for one- and three-trial cocaine-induced behavioral sensitization in preweanling rats.

Authors:  Sanders A McDougall; Anthony M Cortez; Alexandria G Palmer; Matthew S Herbert; Cynthia E Martinez; Sergios Charntikov; Dionisio A Amodeo
Journal:  Psychopharmacology (Berl)       Date:  2009-07-28       Impact factor: 4.530

10.  Social deprivation enhances the vulnerability of male Wistar rats to stressor- and amphetamine-induced behavioral sensitization.

Authors:  S H Ahmed; L Stinus; M Le Moal; M Cador
Journal:  Psychopharmacology (Berl)       Date:  1995-01       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.